Shukra Pharmaceuticals Ltd — Important, 07-05-2026: Company Update

The company's board has approved the financial results for the quarter and financial year ending March 31, 2026. The board also approved a final dividend of Re 0.01 (1%) per equity share for FY 2025-26, awaiting shareholder consent. Key update: 17.35 lakh equity shares were allotted to promoters Dakshesh Shah and Parshva Texchem India Private Limited by converting warrants, generating Rs 4.42 Cr and raising paid-up capital from Rs 43.79 Cr to Rs 43.96 Cr. This shows promoters increasing stake, while 29.08 lakh warrants remain outstanding. Funds from earlier warrant issuance, totaling Rs 3.95 Cr, were utilized as planned, with no deviation.